Literature DB >> 19478237

Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols.

Zoltán Gregus1, Goedele Roos, Paul Geerlings, Balázs Németi.   

Abstract

Enzymes catalyzing the phosphorolytic cleavage of their substrates can reduce arsenate (AsV) to the more toxic arsenite (AsIII) via the arsenolytic substrate cleavage in presence of a reductant, as glutathione or dithiotreitol (DTT). We have shown this for purine nucleoside phosphorylase (PNP), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), glycogen phosphorylase-a (GPa), and phosphotransacetylase (PTA). Using a multidisciplinary approach, we explored the mechanism whereby these enzymes mediate AsV reduction. It is known that PNP cleaves inosine with AsV into hypoxanthine and ribose-1-arsenate. In presence of inosine, AsV and DTT, PNP mediates AsIII formation. In this study, we incubated PNP first with inosine and AsV, allowing the arsenolytic reaction to run, then blocked this reaction with the PNP inhibitor BCX-1777, added DTT and continued the incubation. Despite inhibition of PNP, large amount of AsIII was formed in these incubations, indicating that PNP does not reduce AsV directly but forms a product (i.e., ribose-1-arsenate) that is reduced to AsIII by DTT. Similar studies with the other arsenolytic enzymes (GPa, GAPDH, and PTA) yielded similar results. Various thiols that differentially supported AsV reduction when present during PNP-catalyzed arsenolysis (DTT approximately dimercaptopropane-1-sulfonic acid > mercaptoethanol > DMSA > GSH) similarly supported AsV reduction when added only after a transient PNP-catalyzed arsenolysis, which preformed ribose-1-arsenate. Experiments with progressively delayed addition of DTT after BCX-1777 indicated that ribose-1-arsenate is short-lived with a half-life of 4 min. In conclusion, phosphorolytic enzymes, such as PNP, GAPDH, GPa, and PTA, promote thiol-dependent AsV reduction because they convert AsV into arsenylated products reducible by thiols more readily than AsV. In support of this view, reactivity studies using conceptual density functional theory reactivity descriptors (local softness, nucleofugality) indicate that reduction by thiols of the arsenylated metabolites is favored over AsV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478237     DOI: 10.1093/toxsci/kfp113

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  10 in total

1.  Arsenic exposure and toxicology: a historical perspective.

Authors:  Michael F Hughes; Barbara D Beck; Yu Chen; Ari S Lewis; David J Thomas
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

Review 2.  Individual susceptibility to arsenic-induced diseases: the role of host genetics, nutritional status, and the gut microbiome.

Authors:  Liang Chi; Bei Gao; Pengcheng Tu; Chih-Wei Liu; Jingchuan Xue; Yunjia Lai; Hongyu Ru; Kun Lu
Journal:  Mamm Genome       Date:  2018-02-10       Impact factor: 2.957

3.  OsHAC1;1 and OsHAC1;2 Function as Arsenate Reductases and Regulate Arsenic Accumulation.

Authors:  Shulin Shi; Tao Wang; Ziru Chen; Zhong Tang; Zhongchang Wu; David E Salt; Dai-Yin Chao; Fang-Jie Zhao
Journal:  Plant Physiol       Date:  2016-10-04       Impact factor: 8.340

4.  Adventitious arsenate reductase activity of the catalytic domain of the human Cdc25B and Cdc25C phosphatases.

Authors:  Hiranmoy Bhattacharjee; Ju Sheng; A Abdul Ajees; Rita Mukhopadhyay; Barry P Rosen
Journal:  Biochemistry       Date:  2010-02-02       Impact factor: 3.162

Review 5.  Effects of arsenic exposure on DNA methylation and epigenetic gene regulation.

Authors:  John F Reichard; Alvaro Puga
Journal:  Epigenomics       Date:  2010-02       Impact factor: 4.778

6.  Characterization of arsenate uptake by cultured primary rat astrocytes.

Authors:  Yvonne Koehler; Ralf Dringen
Journal:  Neurochem Res       Date:  2013-06-01       Impact factor: 3.996

7.  Knocking out ACR2 does not affect arsenic redox status in Arabidopsis thaliana: implications for as detoxification and accumulation in plants.

Authors:  Wenju Liu; Henk Schat; Mathijs Bliek; Yi Chen; Steve P McGrath; Graham George; David E Salt; Fang-Jie Zhao
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

8.  Genomic responses to arsenic in the cyanobacterium Synechocystis sp. PCC 6803.

Authors:  Ana María Sánchez-Riego; Luis López-Maury; Francisco Javier Florencio
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

9.  Genome-wide association mapping identifies a new arsenate reductase enzyme critical for limiting arsenic accumulation in plants.

Authors:  Dai-Yin Chao; Yi Chen; Jiugeng Chen; Shulin Shi; Ziru Chen; Chengcheng Wang; John M Danku; Fang-Jie Zhao; David E Salt
Journal:  PLoS Biol       Date:  2014-12-02       Impact factor: 8.029

10.  Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy.

Authors:  Maike Schuldt; Beau van Driel; Sila Algül; Rahana Y Parbhudayal; Daniela Q C M Barge-Schaapveld; Ahmet Güçlü; Mark Jansen; Michelle Michels; Annette F Baas; Mark A van de Wiel; Max Nieuwdorp; Evgeni Levin; Tjeerd Germans; Judith J M Jans; Jolanda van der Velden
Journal:  Cells       Date:  2021-10-29       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.